It is most associated with SGLT2 inhibitors (a different class of diabetes drug) but has been reported with GLP-1 medications in the context of very low carbohydrate intake, particularly during illness, fasting, or periods of very low food intake
Retatrutide is a triple receptor agonist that works to turn on the GLP-1, GIP, and glucagon pathways
PlexusDx eliminates this uncertainty by offering compounded semaglutide at $189/mo month-to-month, or from $149/mo on the 6-month plan without insurance requirements
According to various clinical trials, about 5% to 7% of people taking Zepbound discontinued treatment due to side effects, compared with about 3% in the placebo group
Rare side effects may include pancreatitis, kidney problems, or an increased risk of thyroid cancer
Theres no question that Americans need some help losing weight